Contraception in diabetes mellitus;KONTRAZEPTION BEI DIABETES MELLITUS

Gynakologe

Volumn 31, Issue 1, 1998, Pages 85-90

  Burkart, W ^a,b  

^a Gynakol Praxis Münster ^*

^b Praxis   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRACEPTIVE AGENT; ESTROGEN; ETHINYLESTRADIOL; GESTAGEN; MESTRANOL; NONOXINOL; NORETHISTERONE;

CONDOM; CONTRACEPTION; DIABETES MELLITUS; FEMALE; HUMAN; INTRAUTERINE CONTRACEPTIVE DEVICE; ORAL DRUG ADMINISTRATION; PREGNANCY; SHORT SURVEY; THROMBOEMBOLISM; VASECTOMY;

EID: 0031893698     PISSN: 00175994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001290050227     Document Type: Short Survey

References (38)

1. ACOG Technical Bulletin Number 164 (1993) The intrauterine device. Int J Gynecol Obstet 41: 189
2. Beller FK, Ebert C (1985) Effects of oral contraceptives on blood coagulation. A review. Obstet Gynecol Surv 40: 425
3. Burkart W, Schneider HPG (1988) Die normoglykämische Schwangere - eine Patientin ohne Risiko? In: Dudenhausen JW, Saling E (Hrsg) Perinatale Medizin. Thieme, Stuttgart New York
4. Burkart W (1989) Menarche, Zyklus und Fertilität der Diabetikerin. Geburtshilfe Frauenheilkd 49: 141
5. Burkart W (1989) Geburtshilfliche und gynäkologische Aspekte des Diabetes mellitus. Habilitationsschrift, Universität Münster
6. Burkart W (1992) Auswirkungen des Diabetes mellitus auf die reproduktive Funktion der Frau. Med Welt 43: 677
7. Chasan-Taber L, Willett WC, Masnon JE et al. (1996) Prospective study of oral contraception and hypertension among women in the United States. Circulation 94: 483
8. Chi I (1993) What have we learned from recent IUD studies: A researchers perspective. Contraception 48: 81
9. Croft P, Hannaford PC (1989) Risk factors for acute myocardial infarction on women: Evidence from the Royal College of General Practitioners' Oral Contraception Study. Br Med J 298: 165
10. Döring G, Baur S, Frank P, Freundl G, Sottong U (1986) Ergebnisse einer repräsentativen Umfrage zum Familienplanungsverhalten in der Bundesrepublik Deutschland 1985. Geburtshilfe Frauenheilkd 46: 892
11. Dominick HC, Burkart W (1984) Kinder diabetischer Mütter. Monatsschr Kinderheilkd 132: 886
12. Elstein M, Ezenyiroha M (1984) Hypothesen zur kontrazeptiven Wirkung von Intrauterinpessaren. In: Beller FK, Schweppe KW (Hrsg) Intrauterinpessare. Edition Medizin, Weinheim
13. Farley TMM, Rosenberg MJ, Rowe PJ, Chen J, Meirik O (1992) Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339: 785
14. Grag SK, Chase HP, Marshall G, Hoops SL, Holmes DL, Jackson WE (1994) Oral contraceptives and renal and retinal complications in young women with insulin-dependent diabetes mellitus. JAMA 271: 1099
15. Inman WHW, Vessey MP, Westerholm B, Engelund A (1970) Thromboembolic disease and the steroidal content of oral contraceptives. Am J Epidemiol 110: 188
16. Jick H, Jick SS, Gurewitch V, Myers MW, Vasilakis C (1995) Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 346: 1589
17. Jovanovic L, Peterson CM (1980) Management of the pregnant, insulin-dependent woman. Diabetes Care 3: 63
18. Kimmerle R, Schmitt G, Berger M (1994) Empfängnisverhütung bei Typ-I-Diabetikerinnen: Eine Erhebung bei 808 Frauen im fertilen Alter. Geburtshilfe Frauenheilkd 54: 691
19. Klein BAK, Moss SE, Klein R (1990) Oral contraceptives in women with diabetes. Diabetes Care 13: 895
20. Ledger WJ, Wilson JR (1966) Intrauterine contraceptive devices: The recognition and management of uterine perforations. Obstet Gynecol 28: 806
21. Lippes J (1934) Erfahrungen mit Wirkstoffreien Intrauterinpessaren. In: Beller FK, Schweppe KW (Hrsg) Intrauterinpessare. Edition Medizin, Weinheim
22. Meade TW, Greenburg G, Thompson SG (1980) Progestogens and cardiovascular reactions associated with oral contraceptives and a comparision of the safety of 50- and 30 μg estrogen preparations. Br Med J 280: 1157
23. Neeser E, Hirsch HA (1985) Tubargravidität nach Tubensterilisation. Geburtshilfe Frauenheilkd 45: 702
24. Ramcharan S (ed) (1974) The Walnut Creek Contraceptive Drug Study: A prospective study on the side effects of oral contraceptives. US Government Printing Office, Washington, DC
25. Rosenberg L, Shapiro S, Slone D et al. (1982) Epithelial ovarian cancer and oral contraceptives. J Am Med Ass 247: 3210
26. Roversi GD, Lowy C (1970) Neue Aspekte der Diabetes-Therapie in der Gravidität. In: Saling E, Schulte FJ (Hrsg) Perinatale Medizin. Thieme, Stuttgart New York
27. Schweppe KW, Wagner H (1984) Intra- und extrauterine Graviditäten bei IUP-Anwendung. In: Beller FK, Schweppe KW (Hrsg) Intrauterinpessare. Edition Medizin, Weinheim
28. Spitzer WO, Lewis MA, Heinemann KAJ, Thorogood M, MacRae KD (1996) Third generation oral contraceptives and risk of venous thromboembolic disorders: An international case-control study. Br Med J 312: 83
29. Thorogood M (1993) Oral contraceptives and venous thromboembolism. Gynecol Endocrinol 7 [Suppl]: 3
30. Van Os WAA (1984) Komplikationen bei Intrauterpessaranwendung und ihre Behandlung. In: Beller FK, Schweppe KW (Hrsg) Intrauterinpessare. Edition Medizin, Weinheim
31. Van Santen MR, Haspels AA (1984) Postkoitale Intrauterinpessareinlage. In: Beller FK, Schweppe KW (Hrsg) Intrauterinpessare. Edition Medizin, Weinheim
32. Vessey MR, Lawles M, McPherson K, Yeates D (1985) Progestgen-only oral contraceptives. Findings in a large prospective study with special reference to effectiveness. Br J Fam Plann 10: 117
33. Wild RA (1994) Clinical challenge: The diabetic on OCs. Int J Fertil 39: 148
34. World Health Organization (1994) Oral contraceptives: no apparent association with diabetic complications. WHO Drug Information 8: 135
35. World Health Organization Collaborative Study of cardiovascular disease and steroid hormone contraception (1995a) Venous thromboembolic disease and combined oral contraceptives: Results of international multicentre case-control study. Lancet 346: 1575
36. World Health Organization Collaborative Study of cardiovascular disease and steroid hormone contraception (1995b): Effects of different progestagens in low estrogen oral contraceptives on venous thromboembolic disease. Lancet 346: 1582
37. World Health Organization (1997): Mechanism of action, safety and efficacy of intrauterine devices. Tech Rep Ser WHO, Genf
38. World Health Organization, Special program of research, development, and research training in human reproduction (1990): Task force on the safety and efficacy of fertility regulation methods: The T Cu 380A, T Cu 220 C, Multiload 250, and Nova T IUDs at 3, 5, an 7 years of use: Results from three randomized multicentre trials. Contraception 42: 141